NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
AJOG MFM/LinkedIn
Feb 27, 2026, 08:30

Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM

American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:

” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:

  • Lower risks of very preterm birth and low birth weight
  • Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
  • Persistent increased risk of gestational diabetes

Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.

Read the full text to learn more.”

Proceed to the video attached to the post.

Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn

Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander

AJOG MFM

Stay updated on all scientific advances in the field of fertility with Fertility News.

AJOG MFM Alan S. Brown Aleksi Tornio American Journal of Obstetrics and Gynecology MFM Andre Sourander Birth Outcomes David Gyllenberg Emmi Heinonen Fertility Fertility News Gestational Diabetes Risk Heli Malm Ian W. McKeague Keely Cheslack-Postava low birth weight maternal depression Maternal Health Benefits maternal mental health Mika Gissler Neonatal Adaptation Neonatal Care Pregnancy Complications Pregnancy Research Pregnancy Risks preterm birth SSRI SSRI Exposure Subina Upadhyaya Susanna Hinkka-Yli-Salomäki
NewsFeed